A phase IIa study of rhLTα-Da in combination with cisplatin and fluorouracil for patients with metastatic esophageal squamous cell carcinoma or gastric adenocarcinoma
Crossref DOI link: https://doi.org/10.1007/s12032-016-0846-5
Published Online: 2016-10-14
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Feng-hua
Wang, Yun
Chen, Zhen-dong
Chen, Jian-hua
Qin, Feng-zhan
Jiang, Wen-qi
Li, Yu-hong https://orcid.org/0000-0002-5710-9096
License valid from 2016-10-14